Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The decisive role of molecular pathology in presumed somatic metastases of type II testicular germ cell tumors: report of 2 cases.
Kranendonk MEG, Hackeng WM, Offerhaus GJA, Morsink FHM, Jonges GN, Groenewegen G, Krijtenburg PJ, Klümpen HJ, de Leng WWJ, Looijenga LHJ, Brosens LAA. Kranendonk MEG, et al. Among authors: groenewegen g. Diagn Pathol. 2020 Jul 25;15(1):99. doi: 10.1186/s13000-020-01011-0. Diagn Pathol. 2020. PMID: 32711552 Free PMC article.
Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical Trial.
Cirkel GA, Hamberg P, Sleijfer S, Loosveld OJL, Dercksen MW, Los M, Polee MB, van den Berkmortel F, Aarts MJ, Beerepoot LV, Groenewegen G, Lolkema MP, Tascilar M, Portielje JEA, Peters FPJ, Klümpen HJ, van der Noort V, Haanen JBAG, Voest EE; Dutch WIN-O Consortium. Cirkel GA, et al. Among authors: groenewegen g. JAMA Oncol. 2017 Apr 1;3(4):501-508. doi: 10.1001/jamaoncol.2016.5202. JAMA Oncol. 2017. PMID: 27918762 Clinical Trial.
Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Klümpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, Jóźwiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M. Groot HJ, et al. Among authors: groenewegen g. J Clin Oncol. 2018 Aug 20;36(24):2504-2513. doi: 10.1200/JCO.2017.77.4174. Epub 2018 Jul 10. J Clin Oncol. 2018. PMID: 29989856
Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer.
Blok JM, Groot HJ, Huele EH, de Wit R, Horenblas S, Nuver J, Groenewegen G, Bosch JLHR, Witjes JA, Tromp JM, de Brouwer PJM, van den Berg HA, Vanneste BGL, Smilde TJ, Aarts MJB, Gietema JA, Meijer RP, Schaapveld M. Blok JM, et al. Among authors: groenewegen g. J Clin Oncol. 2021 Feb 1;39(4):319-327. doi: 10.1200/JCO.20.02352. Epub 2020 Oct 29. J Clin Oncol. 2021. PMID: 33119475
Donor-Derived Testicular Germ Cell Cancer in a Heart Transplant Recipient.
Oerlemans MIFJ, Groenewegen G, Vink A, van Laake LW, van der Kaaij NP, de Jonge N. Oerlemans MIFJ, et al. Among authors: groenewegen g. JACC CardioOncol. 2021 Jun 15;3(2):322-325. doi: 10.1016/j.jaccao.2021.02.009. eCollection 2021 Jun. JACC CardioOncol. 2021. PMID: 34396342 Free PMC article. Review. No abstract available.
Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
van Herpen CM, Jansen RL, Kruit WH, Hoekman K, Groenewegen G, Osanto S, De Mulder PH. van Herpen CM, et al. Among authors: groenewegen g. Br J Cancer. 2000 Feb;82(4):772-6. doi: 10.1054/bjoc.1999.0997. Br J Cancer. 2000. PMID: 10732744 Free PMC article. Clinical Trial.
Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers.
Verhaart SL, Abu-Ghanem Y, Mulder SF, Oosting S, Van Der Veldt A, Osanto S, Aarts MJB, Houtsma D, Peters FPJ, Groenewegen G, Van Herpen CML, Pronk LM, Tascilar M, Hamberg P, Los M, Vreugdenhil G, Polee M, Ten Tije AJ, Haanen JBAG, Bex A, van den Eertwegh AJ. Verhaart SL, et al. Among authors: groenewegen g. Clin Genitourin Cancer. 2021 Jun;19(3):274.e1-274.e16. doi: 10.1016/j.clgc.2020.10.003. Epub 2020 Oct 14. Clin Genitourin Cancer. 2021. PMID: 33317946
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C; EORTC Melanoma Group. Eggermont AMM, et al. Lancet Oncol. 2021 May;22(5):643-654. doi: 10.1016/S1470-2045(21)00065-6. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857412 Clinical Trial.
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models.
Vermaat JS, van der Tweel I, Mehra N, Sleijfer S, Haanen JB, Roodhart JM, Engwegen JY, Korse CM, Langenberg MH, Kruit W, Groenewegen G, Giles RH, Schellens JH, Beijnen JH, Voest EE. Vermaat JS, et al. Among authors: groenewegen g. Ann Oncol. 2010 Jul;21(7):1472-1481. doi: 10.1093/annonc/mdp559. Epub 2009 Dec 18. Ann Oncol. 2010. PMID: 20022911 Free article.
66 results